Perineural invasion is a prognostic factor for biochemical failure after radical prostatectomy

International Journal of Urology

Volumn 16, Issue 8, 2009, Pages 682-686

  Jeon, Hwang Gyun ^a   Bae, Jungbum ^a   Yi, Jun Seok ^a   Hwang, In Sik ^a   Lee, Sang Eun ^b   Lee, Eunsik ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

Prostate; Prostate specific antigen; Prostatectomy; Prostatic neoplasms; Recurrence

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CLINICAL EVALUATION; GLEASON SCORE; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NERVE TUMOR; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; SEMINAL VESICLE; TREATMENT FAILURE; VASCULAR TUMOR;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NERVOUS SYSTEM NEOPLASMS; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TREATMENT FAILURE; VASCULAR NEOPLASMS;

EID: 68749102510     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2009.02331.x     Document Type: Article

References (23)

1. Kattan MW, Eastham JA, Stapleton AM, Wheeler TM, Scardino PT. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J. Natl Cancer Inst. 1998 90 : 766 71.
2. Ward JF, Blute ML, Slezak J, Bergstralh EJ, Zincke H. The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy. J. Urol. 2003 170 : 1872 6.
3. Epstein JI, Pizov G, Walsh PC. Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer 1993 71 : 3582 93.
4. Henson DE, Hutter RV, Farrow G. Practice protocol for the examination of specimens removed from patients with carcinoma of the prostate gland. A publication of the Cancer Committee, College of American Pathologists. Task Force on the Examination of Specimens Removed from Patients with Prostate Cancer. Arch. Pathol. Lab. Med. 1994 118 : 779 83.
5. Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J. Urol. 1974 111 : 58 64.
6. Freedland SJ, Mangold LA, Walsh PC, Partin AW. The prostatic specific antigen era is alive and well: prostatic specific antigen and biochemical progression following radical prostatectomy. J. Urol. 2005 174 : 1276 81 discussion 81; author reply 81.
7. Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT. Cancer control with radical prostatectomy alone in 1000 consecutive patients. J. Urol. 2002 167 : 528 34.
8. Han M, Partin AW, Piantadosi S, Epstein JI, Walsh PC. Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. J. Urol. 2001 166 : 416 19.
9. Epstein JI, Amin M, Boccon-Gibod L et al. Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens. Scand. J. Urol. Nephrol. Suppl. 2005 216 : 34 63.
10. Endrizzi J, Seay T. The relationship between early biochemical failure and perineural invasion in pathological T2 prostate cancer. BJU Int. 2000 85 : 696 8.
11. Ozcan F. Correlation of perineural invasion on radical prostatectomy specimens with other pathologic prognostic factors and PSA failure. Eur. Urol. 2001 40 : 308 12.
12. Ng JC, Koch MO, Daggy JK, Cheng L. Perineural invasion in radical prostatectomy specimens: lack of prognostic significance. J. Urol. 2004 172 : 2249 51.
13. Shariat SF, Khoddami SM, Saboorian H et al. Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy. J. Urol. 2004 171 : 1122 7.
14. Maru N, Ohori M, Kattan MW, Scardino PT, Wheeler TM. Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens. Hum. Pathol. 2001 32 : 828 33.
15. Miyake H, Sakai I, Harada K, Eto H, Hara I. Limited value of perineural invasion in radical prostatectomy specimens as a predictor of biochemical recurrence in Japanese men with clinically localized prostate cancer. Hinyokika Kiyo 2005 51 : 241 6.
16. Herman CM, Wilcox GE, Kattan MW, Scardino PT, Wheeler TM. Lymphovascular invasion as a predictor of disease progression in prostate cancer. Am. J. Surg. Pathol. 2000 24 : 859 63.
17. McNeal JE, Yemoto CE. Significance of demonstrable vascular space invasion for the progression of prostatic adenocarcinoma. Am. J. Surg. Pathol. 1996 20 : 1351 60.
18. van den Ouden D, Kranse R, Hop WC, van der Kwast TH, Schroder FH. Microvascular invasion in prostate cancer: prognostic significance in patients treated by radical prostatectomy for clinically localized carcinoma. Urol. Int. 1998 60 : 17 24.
19. de la Taille A, Rubin MA, Buttyan R et al. Is microvascular invasion on radical prostatectomy specimens a useful predictor of PSA recurrence for prostate cancer patients? Eur. Urol. 2000 38 : 79 84.
20. Bahnson RR, Dresner SM, Gooding W, Becich MJ. Incidence and prognostic significance of lymphatic and vascular invasion in radical prostatectomy specimens. Prostate 1989 15 : 149 55.
21. Salomao DR, Graham SD, Bostwick DG. Microvascular invasion in prostate cancer correlates with pathologic stage. Arch. Pathol. Lab. Med. 1995 119 : 1050 4.
22. May M, Kaufmann O, Hammermann F, Loy V, Siegsmund M. Prognostic impact of lymphovascular invasion in radical prostatectomy specimens. BJU Int. 2007 99 : 539 44.
23. Babaian RJ, Troncoso P, Bhadkamkar VA, Johnston DA. Analysis of clinicopathologic factors predicting outcome after radical prostatectomy. Cancer 2001 91 : 1414 22.